NATICK, Mass.–(BUSINESS WIRE)–#biotech—Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the appointment of Myla Lai-Goldman, MD, to its Board of Directors. “Myla’s visionary leadership and extensive experience in diagnostic development and laboratory testing will be another significant catalyst in Mercy’s journey to bring our diagnostic … [Read more…]

Itolizumab in combination with systemic corticosteroids was associated with high rates of overall clinical response Response at Day 29 was associated with improved progression-free survival through 1 year Itolizumab is being evaluated in pivotal Phase 3 EQUATOR study in first-line acute graft-versus-host disease LA JOLLA, Calif.–(BUSINESS WIRE)–$EQ #GVHD—Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company … [Read more…]

Cloud-based platform enables a fast, efficient, and early start on commercialization planning to help emerging biopharma companies successfully deliver medicines at scale BOSTON–(BUSINESS WIRE)–Corval®, the leader in cloud-based commercialization planning for early- to mid-stage biopharma companies, today announced the Corval 2.0 Platform, the second generation of its cloud-based software platform that enables company leaders to … [Read more…]

Ancestry® Survey Uncovers 4 in 5 Moms Want to Share Stories About Their Past, But Majority Say They’re Not Being Asked LEHI, Utah–(BUSINESS WIRE)–Ancestry®, the leader in family history, released survey findings today that revealed Americans have a blind spot about what their parents’ lives were like before parenthood. In fact, only 37% are familiar … [Read more…]

Quantum-Si Strengthens Commercial, Operations, and Development Teams to Accelerate the Commercial Advancement of the Platinum™ Protein Sequencing Platform GUILFORD, Conn.–(BUSINESS WIRE)–#theproteinsequencingcompany—Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointments of Katherine Atkinson as Senior Vice President of Demand Generation and Corporate Brand, Alex Hutcheson as Senior Vice … [Read more…]

Two New OVDs Offer Surgeons Dual-Action Protection during Cataract Surgery VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of StableVisc™ cohesive ophthalmic viscosurgical device (OVD) as well as TotalVisc™ Viscoelastic System. StableVisc … [Read more…]

Dr. Pnina Fishman appointed Executive Chairman of the Board Motti Farbstein appointed Chief Executive Officer in addition to continuing as Chief Financial Officer PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced executive … [Read more…]

Eplontersen halted neuropathy disease progression and improved neuropathy impairment and quality of life WILMINGTON, Del.–(BUSINESS WIRE)–Detailed results from the NEURO-TTRansform Phase III trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) showed AstraZeneca and Ionis’ eplontersen met all co-primary endpoints and secondary endpoints at 66 weeks versus an external placebo group.1 The positive results being … [Read more…]

Mednow to become the preferred virtual pharmacy partner for participating PBAS clients and their members. Prudent Benefits Administration Services, Inc. (“PBAS”) is a leading third-party administrator that delivers comprehensive benefits administration services to over 200,000 Canadians Mednow will become the preferred virtual pharmacy partner for PBAS clients PBAS benefit plans will have access to Mednow’s … [Read more…]

BAUDETTE, Minn.–(BUSINESS WIRE)–ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Nitrofurantoin Oral Suspension USP, 25 mg/5 ml. ANI’s Nitrofurantoin Oral Suspension is the generic version of the Reference Listed Drug (RLD) Furadantin® Oral Suspension … [Read more…]